STAGE IV RENAL CELL CANCER AJCC V7
Clinical trials for STAGE IV RENAL CELL CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV RENAL CELL CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IV RENAL CELL CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy drug shows promise for rare and Hard-to-Treat cancers
Disease control OngoingThis study tests a drug called pembrolizumab (Keytruda) in 157 people with rare cancers that have spread or cannot be removed. The drug helps the immune system fight cancer by blocking a protein that tumors use to hide. The main goal is to see if the drug can stop the cancer from…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:18 UTC
-
New combo therapy shows promise for kidney cancer patients
Disease control OngoingThis early-phase study looks at how safe and effective immunotherapy drugs (nivolumab alone or with bevacizumab or ipilimumab) are when given before surgery to people with kidney cancer that has spread. About 104 participants will receive these treatments to see how the body reac…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V7
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:12 UTC
-
Experimental combo targets Cancer's Self-Eating process
Disease control OngoingThis early-phase trial tests the safety and best dose of combining two drugs—MK-2206 and hydroxychloroquine—in people with advanced solid tumors, melanoma, or prostate or kidney cancer. The goal is to see if blocking a process called autophagy can help kill more cancer cells. Abo…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:10 UTC
-
Can a pill keep kidney cancer away after surgery?
Disease control OngoingThis study tests whether the drug pazopanib can delay or prevent kidney cancer from returning in patients who have had all visible tumors removed by surgery. About 129 adults with advanced kidney cancer that spread to other parts of the body but showed no signs of disease after s…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
New drug cocktail shows promise against tough kidney cancer
Disease control OngoingThis study tests a combination of two drugs—entinostat and aldesleukin—for people with kidney cancer that has spread. The goal is to find the safest dose and see if the combo can shrink tumors. About 47 adults with clear cell kidney cancer are taking part.
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V7
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Inhaled therapy shows promise for lung metastases
Disease control OngoingThis study tests an inhaled form of a protein called interleukin-2 (IL-2) to treat cancers that have spread to the lungs, such as melanoma, kidney cancer, and sarcoma. The goal is to find the safest dose and see if it can shrink tumors. About 70 adults with advanced cancer and lu…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V7
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:40 UTC